AVNS Avanos Medical Inc

Price (delayed)

$47.07

Market cap

$2.25B

P/E Ratio

156.9

Dividend/share

N/A

EPS

$0.3

Enterprise value

$2.39B

Sector: Healthcare
Industry: Medical Devices

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights

The EPS has soared by 188% from the previous quarter and by 134% YoY
The net income has soared by 182% from the previous quarter and by 133% YoY
The gross margin has declined by 6% year-on-year

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
47.83M
Market cap
$2.25B
Enterprise value
$2.39B
Valuations
Price to earnings (P/E)
156.9
Price to book (P/B)
1.75
Price to sales (P/S)
3.13
EV/EBIT
N/A
EV/EBITDA
58.33
EV/Sales
3.32
Earnings
Revenue
$719.6M
EBIT
-$2.4M
EBITDA
$41M
Free cash flow
-$29.7M
Per share
EPS
$0.3
Free cash flow per share
-$0.62
Book value per share
$26.97
Revenue per share
$15.04
TBVPS
$17.31
Balance sheet
Total assets
$1.8B
Total liabilities
$509.2M
Debt
$320.2M
Equity
$1.29B
Working capital
$388.2M
Liquidity
Debt to equity
0.25
Current ratio
3.16
Quick ratio
2.02
Net debt/EBITDA
3.42
Margins
EBITDA margin
5.7%
Gross margin
54.8%
Net margin
1.9%
Operating margin
0.9%
Efficiency
Return on assets
0.8%
Return on equity
1.1%
Return on invested capital
-0.3%
Return on capital employed
-0.1%
Return on sales
-0.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-2.89%
1 week
-2.04%
1 month
-1.59%
1 year
44.43%
YTD
2.59%
QTD
2.59%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$719.6M
Gross profit
$394.1M
Operating income
$6.4M
Net income
$13.9M
Gross margin
54.8%
Net margin
1.9%
The net income has soared by 182% from the previous quarter and by 133% YoY
The operating income has soared by 182% QoQ and by 121% YoY
Avanos Medical's operating margin has soared by 182% from the previous quarter and by 120% YoY
Avanos Medical's net margin has soared by 179% from the previous quarter and by 131% YoY

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
156.9
P/B
1.75
P/S
3.13
EV/EBIT
N/A
EV/EBITDA
58.33
EV/Sales
3.32
The EPS has soared by 188% from the previous quarter and by 134% YoY
AVNS's price to book (P/B) is 46% more than its last 4 quarters average of 1.2 and 9% more than its 5-year quarterly average of 1.6
The company's equity rose by 2.2% QoQ
The P/S is 49% higher than the last 4 quarters average of 2.1 but 27% lower than the 5-year quarterly average of 4.3
The revenue is up by 6% year-on-year and by 2% since the previous quarter

Efficiency

How efficient is Avanos Medical business performance
The return on assets has surged by 189% since the previous quarter and by 135% year-on-year
The ROE has soared by 185% from the previous quarter and by 133% YoY
AVNS's ROIC has soared by 96% YoY and by 89% from the previous quarter
The ROS has soared by 96% YoY and by 89% from the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The company's current ratio rose by 26% YoY and by 7% QoQ
The quick ratio has increased by 18% year-on-year and by 10% since the previous quarter
Avanos Medical's debt is 75% less than its equity
The debt to equity has contracted by 3.8% from the previous quarter and by 3.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.